Subsense is an Invasive Cortical Implants company founded in 2020 and based in Paris, France. It has raised $27M in total funding, most recently a Seed in 2025.
| Date | Stage | Amount | Valuation | Lead investors |
|---|---|---|---|---|
| Dec 11, 2025 | Seed | $10M | — | Golden Falcon Capital |
| Feb 18, 2025 | Seed | $17M | — | Golden Falcon Capital |
No articles ingested yet for Subsense. Once the hourly news pipeline is live, every article the classifier tags as mentioning this company appears here with its one-line AI summary and sentiment.
A non-surgical brain-computer interface approach using inhalable plasmonic nanoparticles for neural signal sensing and magnetoelectric nanoparticles for targeted neurostimulation — no implant surgery required. Nanoparticles are engineered to cross the blood-brain barrier and self-organize near neurons. In pre-clinical R&D phase; emerged from stealth with $17M seed in February 2025 and has since raised $27M total. Developed in partnership with leading academic collaborators using AI-assisted nanostructure design.